In BLCA cells, reduced METTL3 and YTHDF1 expression shortens the half-life of RPN2 mRNA and protein and leads to diminished PI3K-AKT-mTOR phosphorylation, resulting in reduced cell proliferation and cisplatin sensitivity. Here, MTOR is linked to bladder transitional cell carcinoma.